Cryo Cell International (CCEL) Other Operating Expenses (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Other Operating Expenses data on file, last reported at $1.8 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $1.8 million, down 15.44% year-over-year; the trailing twelve-month figure through Feb 2026 was $12.2 million (up 39.31% YoY), and the FY2025 annual result was $11.6 million, up 34.1% from the prior year.
• Other Operating Expenses eased to $1.8 million in Q1 2026 per CCEL's latest filing, from $6.3 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $18.2 million in Q4 2023 and troughed at $1.8 million in Q4 2024.
• A 5-year average of $3.4 million and a median of $2.3 million in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses surged 600.25% in 2023, then slumped 89.91% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $2.6 million in 2022, then surged by 600.25% to $18.2 million in 2023, then tumbled by 89.91% to $1.8 million in 2024, then soared by 242.49% to $6.3 million in 2025, then sank by 70.68% to $1.8 million in 2026.
• Business Quant data shows CCEL's Other Operating Expenses at $1.8 million in Q1 2026, $6.3 million in Q4 2025, and $2.0 million in Q3 2025.